Quantitative assessment of the association between XPC Lys939Gln polymorphism and cutaneous melanoma risk

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Tumor Biology

• Publication date

  2014-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s13277-013-1196-yPMID 24277375
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• DNA repair variants, indoor tanning, and risk of melanoma

  2013cited by this paper
• New developments in biomarkers for melanoma

  2013cited by this paper
• A meta-analysis of evidences on XPC polymorphisms and lung cancer susceptibility

  2013cited by this paper
• Assessment of the XPC (A2920C), XPF (T30028C), TP53 (Arg72Pro) and GSTP1 (Ile105Val) polymorphisms in the risk of cutaneous melanoma

  2013cited by this paper
• Xeroderma pigmentosum genes and melanoma risk

  2013cited by this paper
• An association between XPC Lys939Gln polymorphism and the risk of bladder cancer: a meta-analysis

  2013cited by this paper
• Advances in the management of melanoma: targeted therapy, immunotherapy and future directions

  2012cited by this paper
• Update on melanoma and non-melanoma skin cancer

  2011cited by this paper
• European ancestry and polymorphisms in DNA repair genes modify the risk of melanoma: a case-control study in a high UV index region in Brazil.

  2011cited by this paper
• DNA interstrand crosslink repair and cancer

  2011cited by this paper
• Chemical investigation of light induced DNA bipyrimidine damage and repair.

  2011cited by this paper
• The role of XPC: implications in cancer and oxidative DNA damage.

  2011cited by this paper
• Current evidences on XPC polymorphisms and breast cancer susceptibility: a meta-analysis

  2011cited by this paper
• Chemical Investigation of Light Induced DNA Bipyrimidine Damage and Repair

  2011cited by this paper
• Screening for Skin Cancer: An Update of the Evidence for the U.S. Preventive Services Task Force

  2009cited by this paper
• Polymorphisms in the DNA Repair Genes XPC, XPD, and XPG and Risk of Cutaneous Melanoma: a Case-Control Analysis

  2006cited by this paper
• Polymorphisms in nucleotide excision repair genes and risk of multiple primary melanoma: the Genes Environment and Melanoma Study.

  2006cited by this paper
• Assessment of 3 xeroderma pigmentosum group C gene polymorphisms and risk of cutaneous melanoma: a case-control study.

  2005cited by this paper
• Cutaneous melanoma: update on prevention, screening, diagnosis, and treatment.

  2005cited by this paper
• Measuring inconsistency in meta-analyses

  2003cited by this paper
• Bias in meta-analysis detected by a simple, graphical test

  1997cited by this paper
• Meta-analysis in clinical trials.

  1986cited by this paper
• Statistical aspects of the analysis of data from retrospective studies of disease.

  1959cited by this paper

• Identification of hub genes correlated with diabetic retinopathy via bioinformatics methods.

  2023cites this paper
• Association of XPC Polymorphisms with Cutaneous Malignant Melanoma Risk: Evidence from a Meta-Analysis.

  2020cites this paper
• Oral Manifestations of Nutritional Deficiencies: Single Centre Analysis.

  2020cites this paper
• A meta‐analysis of XPC Lys939Gln polymorphism and melanoma susceptibility

  2016cites this paper
• Lack of association between XPC Lys939Gln polymorphism and prostate cancer risk: an updated meta-analysis based on 3039 cases and 3253 controls.

  2015cites this paper
• A functional single‐nucleotide polymorphism in the ERCC1 gene alters the efficacy of narrowband ultraviolet B therapy in patients with active vitiligo in a Chinese population

  2015cites this paper